©The Author(s) 2015.
World J Virology. Nov 12, 2015; 4(4): 323-342
Published online Nov 12, 2015. doi: 10.5501/wjv.v4.i4.323
Published online Nov 12, 2015. doi: 10.5501/wjv.v4.i4.323
Table 1 Clinical significance of hepatitis B virus serological markers
| Marker | Clinical significance |
| HBsAg | First marker to appear in course of infection |
| Appears one to 3 wk before the onset of symptoms | |
| The permanence of this marker for more than 24 wk indicates chronicity | |
| Anti-HBc IgM | Marker of recent infection marker |
| Appears with the onset of symptoms and persists up to 32 wk after infection | |
| Anti-HBc IgG | This marker did not indicate immunity and it is not elicited by vaccination |
| This presence indicates prior contact with the virus | |
| HBeAg | It appears before the onset of symptoms and indicates viral replication independent of disease phase (acute or chronic) |
| This presence indicates high infectivity | |
| Anti-HBe | It appears after the disappearance of HBeAg |
| Their presence suggests reduction or absence of viral replication, except when infection is due to HBV strains with pre-core mutant (not producing the protein “e”) | |
| Anti-HBs | It appears one to 3 mo after HBV vaccination or after recovery of HBV acute infection and indicates immunity to HBV infection |
- Citation: Villar LM, Cruz HM, Barbosa JR, Bezerra CS, Portilho MM, Scalioni LP. Update on hepatitis B and C virus diagnosis. World J Virology 2015; 4(4): 323-342
- URL: https://www.wjgnet.com/2220-3249/full/v4/i4/323.htm
- DOI: https://dx.doi.org/10.5501/wjv.v4.i4.323